TELO (Telomir Pharmaceuticals) Market Cap : $150.72 Mil (As of Dec. 12, 2024)

View and export this data going back to 2024. Start your Free Trial

What is Telomir Pharmaceuticals Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Telomir Pharmaceuticals's share price for the quarter that ended in Sep. 2024 was $6.42. Telomir Pharmaceuticals's Shares Outstanding (EOP) for the quarter that ended in Sep. 2024 was 29.61 Mil. Therefore, Telomir Pharmaceuticals's market cap for the quarter that ended in Sep. 2024 was $190.09 Mil.

Telomir Pharmaceuticals's quarterly market cap declined from Mar. 2024 ($152.49 Mil) to Jun. 2024 ($142.42 Mil) but then increased from Jun. 2024 ($142.42 Mil) to Sep. 2024 ($190.09 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Telomir Pharmaceuticals's Enterprise Value for Today is $151.11 Mil.

Telomir Pharmaceuticals Market Cap Historical Data

The historical data trend for Telomir Pharmaceuticals's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Telomir Pharmaceuticals Market Cap Chart

Telomir Pharmaceuticals Annual Data

Trend

Dec21

Dec22

Dec23

Market Cap

Telomir Pharmaceuticals Quarterly Data
	Dec21	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Market Cap	Get a 7-Day Free Trial						-	-	152.49	142.42	190.09

Competitive Comparison of Telomir Pharmaceuticals's Market Cap

For the Biotechnology subindustry, Telomir Pharmaceuticals's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Telomir Pharmaceuticals's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Telomir Pharmaceuticals's Market Cap distribution charts can be found below:

* The bar in red indicates where Telomir Pharmaceuticals's Market Cap falls into.

Telomir Pharmaceuticals Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Telomir Pharmaceuticals's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )	=	Share Price (A: Dec. 2023 )	*	Shares Outstanding (EOP) (A: Dec. 2023 )
	=	$0	*	29.6098
	=	$0.00

Telomir Pharmaceuticals's Market Cap for the quarter that ended in Sep. 2024 is calculated as

Market Cap (Q: Sep. 2024 )	=	Share Price (Q: Sep. 2024 )	*	Shares Outstanding (EOP) (Q: Sep. 2024 )
	=	$6.42	*	29.6098
	=	$190.09

Telomir Pharmaceuticals (NAS:TELO) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

Telomir Pharmaceuticals Market Cap Related Terms

Thank you for viewing the detailed overview of Telomir Pharmaceuticals's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.

Telomir Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Telomir Pharmaceuticals Inc (NAS:TELO) » Definitions » Market Cap

Comparable Companies

Traded in Other Exchanges

N/A

Address

855 N Wolfe Street, Suite 601, Baltimore, MD, USA, 21205

Website

https://www.telomirpharma.com

Telomir Pharmaceuticals Inc is a pioneering preclinical-stage pharmaceutical company leading the advancement of age-reversal science. The Company is focused on developing Telomir-1, a novel small molecule designed to lengthen and protect telomeres-the protective DNA end caps of chromosomes that are crucial to cellular aging. As humans and animals age, telomeres naturally shorten, with metal reactivity accelerating this process, increasing the risk of degenerative and age-related diseases. By addressing the underlying causes of aging at the cellular level, Telomir aims to tackle the root of these conditions rather than simply treating their symptoms. Telomir is conducting ongoing preclinical research into Progeria, diabetes, cancer, Alzheimer's disease, osteoarthritis, and others.